Senescence marker protein-30/gluconolactonase deficiency exacerbates diabetic nephropathy through tubular injury in a mouse model of type 1 diabetes

Journal of Diabetes Investigation

Volumn 6, Issue 1, 2015, Pages 35-43

  Okada, Hiroshi ^a   Senmaru, Takafumi ^a   Fukui, Michiaki ^a   Kondo, Yoshitaka ^b   Ishigami, Akihito ^b   Maruyama, Naoki ^b   Obayashi, Hiroshi ^c   Yamazaki, Masahiro ^a   Nakamura, Naoto ^a   Hasegawa, Goji ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b TOKYO METROPOLITAN INSTITUTE OF GERONTOLOGY   (Japan)

^c Institute of Bio Response Informatics   (Japan)

Author keywords

Diabetic nephropathy; Senescence marker protein 30; Tubular injury

Indexed keywords

GLUCONOLACTONASE; HYPOXIA INDUCIBLE FACTOR 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; REGUCALCIN;

AGING; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; CONTROLLED STUDY; DIABETIC NEPHROPATHY; DISEASE COURSE; DISEASE EXACERBATION; GENE DELETION; GENE EXPRESSION; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INCIDENCE; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY FIBROSIS; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DISORDER; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SMP30 GENE;

EID: 84920265730     PISSN: 20401116     EISSN: 20401124     Source Type: Journal    
DOI: 10.1111/jdi.12252     Document Type: Article

References (35)

1. Najafian B, Mauer M. Progression of diabetic nephropathy in type 1 diabetic patients. Diabetes Res Clin Pract 2009; 83: 1-8.
2. Dalla Vestra M, Saller A, Bortoloso E, et al. Structural involvement in type 1 and type 2 diabetic nephropathy. Diabetes Metab 2000; 26: 8-14.
3. Kaissling B, Lehir M, Kriz W. Renal epithelial injury and fibrosis. Biochim Biophys Acta 2013; 1832: 931-939.
4. Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney. Am J Physiol Regul Integr Comp Physiol 2011; 300: 1009-1022.
5. Nangaku M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. J Am Soc Nephrol 2006; 17: 17-25.
6. Fujita T, Uchida K, Maruyama N. Purification of senescence marker protein-30 (SMP30) and its androgen-independent decrease with age in the rat liver. Biochim Biophys Acta 1992; 1116: 122-128.
7. Ishigami A, Maruyama N. Significance of SMP30 in gerontology. Geriatr Gerontol Int 2007; 7: 316-325.
8. Maruyama N, Ishigami A, Kondo Y. Pathophysiological significance of senescence marker protein-30. Geriatr Gerontol Int 2010; 10: S88-S98.
9. 2+-pumping activity in Hep G2 cells. Biochem Biophys Res Commun 1998; 250: 374-380.
10. Kondo Y, Inai Y, Sato Y, et al. Senescence marker protein 30 functions as gluconolactonase in L-ascorbic acid biosynthesis, and its knockout mice are prone to scurvy. Proc Natl Acad Sci USA 2006; 103: 5723-5728.
11. Ishigami A, Fujita T, Handa S, et al. Senescence marker protein-30 knockout mouse liver is highly susceptible to tumor necrosis factor-alpha- and Fas mediated apoptosis. Am J Pathol 2002; 161: 1273-1281.
12. Ishigami A, Kondo Y, Nanba R, et al. SMP30 deficiency in mice causes an accumulation of neutral lipids and phospholipids in the liver and shortens the life span. Biochem Biophys Res Commun 2004; 315: 575-580.
13. Sato T, Seyama K, Sato Y, et al. Senescence marker protein-30 protects mice lungs from oxidative stress, aging, and smoking. Am J Respir Crit Care Med 2006; 174: 530-537.
14. Son TG, Zou Y, Jung KJ, et al. SMP30 deficiency causes increased oxidative stress in brain. Mech Ageing Dev 2006; 127: 451-457.
15. Yumura W, Imasawa T, Suganuma S, et al. Accelerated tubular cell senescence in SMP30 knockout mice. Histol Histopathol 2006; 21: 1151-1156.
16. Hasegawa G, Yamasaki M, Kadono M, et al. Senescence marker protein-30/gluconolactonase deletion worsens glucose tolerance through impairment of acute insulin secretion. Endocrinology 2010; 151: 529-536.
17. Park H, Ishigami A, Shima T, et al. Hepatic senescence marker protein-30 is involved in the progression of nonalcoholic fatty liver disease. J Gastroenterol 2010; 45: 426-434.
18. Coresh J, Astor BC, Greene T, et al. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 1-12.
19. Kiss E, Popovic ZV, Bedke J, et al. Peroxisome proliferator-activated receptor (PPAR) gamma can inhibit chronic renal allograft damage. Am J Pathol 2010; 176: 2150-2162.
20. Kiss E, Adams J, Gröne HJ, et al. Isotretinoin ameliorates renal damage in experimental acute renal allograft rejection. Transplantation 2003; 15: 480-489.
21. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delatta Delta CT) Method. Methods 2001; 25: 402-408.
22. Schofield CJ, Ratcliffe PJ. Oxygen sensing by HIF hydroxylases. Nat Rev Mol Cell Biol 2004; 5: 343-354.
23. Stroka DM, Burkhardt T, Desbaillets I, et al. HIF-1 is expressed in normoxic tissue and displays an organ-specific regulation under systemic hypoxia. FASEB J 2001; 15: 2445-2453.
24. Higgins DF, Biju MP, Akai Y, et al. Hypoxic induction of Ctgf is directly mediated by Hif-1. Am J Physiol Renal Physiol 2004; 287: 1223-1232.
25. Higgins DF, Kimura K, Bernhardt WM, et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. J Clin Invest 2007; 117: 3810-3820.
26. Wada T, Furuichi K, Sakai N, et al. Up-regulation of monocyte chemoattractant protein-1 in tubulointerstitial lesions of human diabetic nephropathy. Kidney Int 2000; 58: 1492-1499.
27. Wenz T. Mitochondria and PGC-1α in aging and age-associated diseases. J Aging Res 2011; 2011: 810619.
28. Anders HJ, Ryu M. Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 2011; 80: 915-925.
29. Kimura K, Iwano M, Higgins DF, et al. Stable expression of HIF-1alpha in tubular epithelial cells promotes interstitial fibrosis. Am J Physiol Renal Physiol 2008; 295: 1023-1029.
30. Ichas F, Mazat JP. From calcium signaling to cell death: two conformations for the mitochondrial permeability transition pore. Switching from low- to high-conductance state. Biochim Biophys Acta 1998; 1366: 33-50.
31. Huang X, Zhai D, Huang Y. Dependence of permeability transition pore opening and cytochrome C release from mitochondria on mitochondria energetic status. Mol Cell Biochem 2001; 224: 1-7.
32. Halestrap AP, Brenner C. The adenine nucleotide translocase: a central component of the mitochondrial permeability transition pore and key player in cell death. Curr Med Chem 2003; 10: 1507-1525.
33. Ishii K, Tsubaki T, Fujita K, et al. Immunohistochemical localization of senescence marker protein-30 (SMP30) in the submandibular gland and ultrastructural changes of the granular duct cells in SMP30 knockout mice. Histol Histopathol 2005; 20: 761-768.
34. Shoag J, Arany Z. Regulation of hypoxia-inducible genes by PGC-1 alpha. Arterioscler Thromb Vasc Biol 2010; 30: 662-666.
35. Lin Y, Kuro-o M, Sun Z. Genetic deficiency of anti-aging gene klotho exacerbates early nephropathy in STZ-induced diabetes in male mice. Endocrinology 2013; 154: 3855-3863.